Arbitrability of healthcare and medical tourism Conflicts in India A comparative study of US & EU Jurisdictions. Abstract: Paper focuses on arbitrability of medical disputes and m ...

If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not ...

DelveInsight's "ENTYVIO Market Size, Forecast, and Market Insight Report" highlights the details around ENTYVIO, a gut-selective ...

DelveInsight's “Musculoskeletal Pain Market Insight, Epidemiology and Market Forecast – 2034” report delivers an in-depth ...

Learn more about whether CRISPR Therapeutics AG or Neurocrine Biosciences, Inc. is a better investment based on AAII's A+ ...

The Japan Pruritus Therapeutics Market, valued at US$ 582.2 million in 2023, is set to experience robust growth over the forecast period. With an expected market size of US$ 1,011.5 million by 2032, ...

The RSUs and stock options are subject to approval by regulatory authorities. About NP-251 (Repirinast) Repirinast was originally developed by Mitsubishi Tanabe Pharma (“Mitsubishi”) and was sold and ...

(Image Source: Pixabay) Even as the pharma sector is still grappling with the uncertainty around the US tariffs, the department of pharmaceuticals (DoP) is planning to get a study done to overhaul ...

Donald Trump's tariffs could disrupt the supply of medicines into the UK, the health secretary has warned. Wes Streeting said the government was "constantly watching and acting on this situation ...

The RSUs and stock options are subject to approval by regulatory authorities. About NP-251 (Repirinast) Repirinast was originally developed by Mitsubishi Tanabe Pharma ("Mitsubishi") and was sold and ...

FRANKFURT/LONDON: European pharma companies warned the European Commission president at a meeting on Tuesday that U.S. tariffs would expedite the industry’s shift away from Europe and toward the ...